ASTM F1088-23 standard analysis laboratory

You want to analyse the beta-tricalcium content of your DM in accordance with ASTM F1088-23

Firstly, the ASTM F1088-23 specification is evolving to meet the requirements of ICH Q3D and USP 233.

What does ASTM F1088-23 say ?

ASTM F1088-23 covers the chemical and crystallographic requirements of biocompatible beta-tricalcium phosphate for surgical implant applications. Elemental analysis of calcium and phosphorus will be consistent with the expected stoichiometry of beta-tricalcium phosphate.

Calcium and phosphorus content should be determined using an appropriate method such as X-ray fluorescence. Quantitative X-ray diffraction (XRD) analysis should indicate a minimum beta-tricalcium phosphate content of 95%, as determined by the powder diffraction method.

The FILAB laboratory can assist you with your analysis needs in accordance with ASTM F1088-23 standard

Importance of the ASTM F1088-23 standard

ASTM F1088-23 is a fundamental pillar of the hydroxyapatite and beta-tricalcium phosphate medical device industry. It guarantees that these materials comply with the most stringent quality requirements. It thus promotes the safety and effectiveness of medical devices, and improves patients’ lives.

dispositifs médicaux

To find out more about these standards and how they apply to your sector, please contact us. We’re here to guide you towards high-quality, standards-compliant solutions for your medical devices.

Why carry out analyses in accordance with ASTM F1088-23 standards ?

The ASTM F1088-23 standard is crucial for the medical devices sector for several reasons :

Quality Assurance : This guarantees that the beta-tricalcium phosphate materials used in medical devices comply with strict quality standards.
Patient Safety: By complying with these standards, medical devices are more likely to be safe to use and minimise risks to patients.
Clinical Effectiveness : ASTM F1088-23 standards contribute to the clinical effectiveness of medical devices, guaranteeing their reliability and performance.
Ease of comparison : This standard enables medical device manufacturers and regulators to compare and assess products in a consistent way.
Continuous Innovation : This encourages innovation by providing guidelines for the development of new medical devices based on beta-TCP (Ca3(PO4)2).

The FILAB laboratory has developed a wide range of skills in chemical analysis and materials characterisation to provide you with a comprehensive service for the chemical characterisation of all your biomaterials :

analyses par tamisage

With our 3 levels of services – analysis, expertise and R&D support – our laboratory supports industrial companies of all sizes and in all sectors in solving their industrial problems. FILAB puts the know-how and expertise of its team at your disposal and provides you with a dedicated technical contact.

The positive aspects of FILAB

  • A highly qualified team

  • Responsiveness in responding to and processing requests

  • A complete analytical park of 2100m²

  • Tailor-made support

Thomas ROUSSEAU
Thomas ROUSSEAU Scientific and Technical Director
Ask for your quote
+33 (0)3 80 52 32 05 Request
a quote